C4 Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $400.1M
Liabilities Breakdown FY2020
Total Liabilities: $119.3M
Asset Breakdown
Total Assets: $400.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $181.7M | 45.4% |
| Accounts Receivable | $4.5M | 1.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.3M | 0.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $210.6M | 52.6% |
Liabilities Breakdown
Total Liabilities: $119.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.7M | 4.8% |
| Long-Term Debt | $10.1M | 8.4% |
| Other Liabilities | $103.6M | 86.8% |